Clinical Trials Browser

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms

NCT01739465 2013-02-26

Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma

Phase 2/3 Unknown

120 enrolled

Gastrointestinal

Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, Carcinoma, Constriction, Pathologic, Digestive System Diseases, Neoplasms, Neoplasms by Site, Cholangiocarcinoma

NCT01786278 2013-02-07

BRASTEGAC

Phase 2/3 Unknown

80 enrolled

Adenocarcinoma, Deglutition Disorders

NCT01523015 2013-02-05

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

Phase 2/3 Unknown

100 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT00127478 2007-11-29

A Long Term Safety Study With Atrasentan

Phase 2/3 Completed

166 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

Clinical Trials

PRO-BOOST-LC

Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer

68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI

NICE

POWERRANGER

Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer

Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma

BRASTEGAC

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

A Long Term Safety Study With Atrasentan